We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly Prevails in Suit Against HHS Over 340B Drug Price Program
Eli Lilly Prevails in Suit Against HHS Over 340B Drug Price Program
A federal judge has ruled that HHS acted incorrectly in warning drugmakers that ending discounts via the 340B Drug Price Program would constitute a violation of the law.